144 related articles for article (PubMed ID: 19614686)
21. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study.
Rossi P; Faroni JV; Nappi G
Cephalalgia; 2008 Nov; 28(11):1196-200. PubMed ID: 18727648
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire.
Lipton RB; Stewart WF; Sawyer J; Edmeads JG
Headache; 2001 Oct; 41(9):854-61. PubMed ID: 11703471
[TBL] [Abstract][Full Text] [Related]
23. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
24. Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication.
Chayasirisobhon S
Headache; 2006 May; 46(5):788-93. PubMed ID: 16643582
[TBL] [Abstract][Full Text] [Related]
25. Headache prevention outcome and body mass index.
Bigal ME; Gironda M; Tepper SJ; Feleppa M; Rapoport AM; Sheftell FD; Lipton RB
Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246
[TBL] [Abstract][Full Text] [Related]
26. Headache characteristics and chronification of migraine and tension-type headache: A population-based study.
Ashina S; Lyngberg A; Jensen R
Cephalalgia; 2010 Aug; 30(8):943-52. PubMed ID: 20656705
[TBL] [Abstract][Full Text] [Related]
27. Occipital nerve stimulation for chronic migraine: a randomized trial.
Serra G; Marchioretto F
Pain Physician; 2012; 15(3):245-53. PubMed ID: 22622909
[TBL] [Abstract][Full Text] [Related]
28. Migraine days decline with duration of illness in adolescents with transformed migraine.
Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
[TBL] [Abstract][Full Text] [Related]
29. Intradiscal electrothermal annuloplasty therapy: a case series study leading to new considerations.
Bryce DA; Nelson J; Glurich I; Berg RL
WMJ; 2005 Aug; 104(6):39-46. PubMed ID: 16218315
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive inpatient treatment of refractory chronic daily headache.
Lake AE; Saper JR; Hamel RL
Headache; 2009 Apr; 49(4):555-62. PubMed ID: 19245391
[TBL] [Abstract][Full Text] [Related]
31. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
[TBL] [Abstract][Full Text] [Related]
32. Probable medication-overuse headache: the effect of a 2-month drug-free period.
Zeeberg P; Olesen J; Jensen R
Neurology; 2006 Jun; 66(12):1894-8. PubMed ID: 16707727
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
34. Functional-MRI evaluation of pain processing in chronic migraine with medication overuse.
Chiapparini L; Grazzi L; Ferraro S; Mandelli ML; Usai S; Andrasik F; Bruzzone MG; Bussone G
Neurol Sci; 2009 May; 30 Suppl 1():S71-4. PubMed ID: 19415430
[TBL] [Abstract][Full Text] [Related]
35. Orbitofrontal dysfunction and medication overuse in patients with migraine.
Biagianti B; Grazzi L; Gambini O; Usai S; Muffatti R; Scarone S; Bussone G
Headache; 2012; 52(10):1511-9. PubMed ID: 23145856
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
Wang SJ; Fuh JL; Lu SR; Juang KD
Neurology; 2007 Feb; 68(8):591-6. PubMed ID: 17182975
[TBL] [Abstract][Full Text] [Related]
37. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Pinus radiata bark extract and vitamin C combination product as a prophylactic therapy for recalcitrant migraine and long-term results.
Chayasirisobhon S
Acta Neurol Taiwan; 2013 Mar; 22(1):13-21. PubMed ID: 23479241
[TBL] [Abstract][Full Text] [Related]
39. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project).
Bendtsen L; Munksgaard S; Tassorelli C; Nappi G; Katsarava Z; Lainez M; Leston J; Fadic R; Spadafora S; Stoppini A; Jensen R;
Cephalalgia; 2014 May; 34(6):426-33. PubMed ID: 24322480
[TBL] [Abstract][Full Text] [Related]
40. Disability and mood state in patients with episodic and chronic migraine associated to medication overuse.
Raggi A; Giovannetti AM; Leonardi M; Schiavolin S; D'Amico D; Curone M; Usai S; Bussone G; Grazzi L
Neurol Sci; 2012 May; 33 Suppl 1():S169-71. PubMed ID: 22644196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
